TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9586908

Group type: EXPERIMENTAL
Intervention: SCF 10 microg/kg daily plus filgrastim 12 microg/kg daily for 6 days
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: SCF pretreatment (10 microg/kg daily starting 3 days before filgrastim for a total of 10 days)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Filgrastim alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: SCF and filgrastim
Number of subjects: 62
Study: 7981925

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (30 mg 4 times daily for 5 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ketorolac tromethamine and Placebo
Number of subjects: 20
Study: 2556540

Group type: EXPERIMENTAL
Intervention: Anti-smoking advice provided by nurses during health checks
Number of subjects: 4210

Group type: COMPARATOR
Intervention: Control group (no anti-smoking advice)
Number of subjects: 4210

Group type: EXPERIMENTAL
Intervention: Attendance at health check after intervention
Number of subjects: 4210

Group type: EXPERIMENTAL
Intervention: Urinary cotinine measurement
Number of subjects: 4210
Study: 5335460

Group type: EXPERIMENTAL
Intervention: Kaolin-agglutination test (KAT)
Number of subjects: 0
Study: 36250

Group type: EXPERIMENTAL
Intervention: Indoramin (76 mg/day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Prazosin (8.2 mg/day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combination of alpha‐adrenoreceptor blockers with beta‐adrenoreceptor blockade
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no specific control mentioned)
Number of subjects: 21
Study: 30866672

Group type: EXPERIMENTAL
Intervention: Suicide-prevention outreach interventions
Number of subjects: 122873

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 122873
Study: 28884798

Group type: EXPERIMENTAL
Intervention: Proper care and good hygiene of the normal mature neonatal skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimizing epidermal barrier integrity (bathing and using emollient)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baby bath products and baby wipes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cleansers specially designed for baby's skin (pH neutral and very mild)
Number of subjects: 0
Study: 25445632

Group type: EXPERIMENTAL
Intervention: L-arginine + nitrate (6 g L-arginine and 614 mg nitrate)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nitrate alone (614 mg nitrate)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: L-arginine + nitrate and nitrate alone
Number of subjects: 9
Study: 24621441

Group type: EXPERIMENTAL
Intervention: Iron supplements
Number of subjects: 2118

Group type: EXPERIMENTAL
Intervention: Folic acid supplements
Number of subjects: 2118

Group type: EXPERIMENTAL
Intervention: Multivitamin use
Number of subjects: 2118

Group type: EXPERIMENTAL
Intervention: Vitamin E supplements in combination with multivitamin
Number of subjects: 2118
Study: 22028420

Group type: EXPERIMENTAL
Intervention: Pictogram-enhanced medication information
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard counseling (Control)
Number of subjects: 82
Study: 19302637

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention with weekly meetings or telephone counselling and free nicotine replacement therapy (NRT) initiated 4 weeks prior to surgery.
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group received standard care.
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention with weekly meetings or telephone counselling and free nicotine replacement therapy (NRT) after 1 year.
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group received standard care after 1 year.
Number of subjects: 117
Study: 17515020

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) for 8 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (non-depressed post-CABG women)
Number of subjects: 15
Study: 15482971

Group type: EXPERIMENTAL
Intervention: Qualitative examination of perceptions of young fathers toward early childbearing issues.
Number of subjects: 0
Study: 11246659

Group type: EXPERIMENTAL
Intervention: 50 mg LJP 394 weekly
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 10 mg LJP 394 weekly
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 9543190

Group type: EXPERIMENTAL
Intervention: 5‐min scaling (method 1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 4‐min scaling and 1 min instrumentation with a perio‐diamond bur (15 microm) (method 2)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 3‐min scaling, 1‐min instrumentation with a perio‐diamond bur (15 microm) and 1 min with an air abrasive system (method 3)
Number of subjects: 11

Group type: COMPARATOR
Intervention: no treatment (control)
Number of subjects: 11
Study: 8289849

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (45 minutes per day, 5 days per week for 12 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 3353043

Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulus
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sham stimulus
Number of subjects: 132
Study: 30520017

Group type: EXPERIMENTAL
Intervention: Perpendicular approach
Number of subjects: 16

Group type: COMPARATOR
Intervention: Parallel approach
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 16
Study: 25382805

Group type: EXPERIMENTAL
Intervention: Spectra Optia
Number of subjects: 32

Group type: COMPARATOR
Intervention: COBE Spectra
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 32
Study: 24660604

Group type: EXPERIMENTAL
Intervention: Reduning injection and Western Medicine (Group C)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Western Medicine (Group A)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Reduning injection (Group B)
Number of subjects: 360
Study: 21261434

Group type: EXPERIMENTAL
Intervention: Craving module intervention
Number of subjects: 776
Study: 19691852

Group type: EXPERIMENTAL
Intervention: 3 mL of intravenous-grade 70% ethanol into each lumen of the catheter once a week
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard heparin locks only
Number of subjects: 112
Study: 16501263

Group type: EXPERIMENTAL
Intervention: Self-assessment questions in Web-based modules
Number of subjects: 121
Study: 15592192

Group type: COMPARATOR
Intervention: Noncorrected Tc-99m tetrofosmin SPECT
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Attenuation-corrected Tc-99m tetrofosmin SPECT
Number of subjects: 33

Group type: COMPARATOR
Intervention: FDG SPECT
Number of subjects: 33
Study: 11450868

Group type: EXPERIMENTAL
Intervention: Amoxicillin 3 g and clavulanic acid 750 mg, 1 dose daily for 2 days
Number of subjects: 15
Study: 9496918

Group type: EXPERIMENTAL
Intervention: Extensive amalgam restorations with auxiliary retention methods
Number of subjects: 300

Group type: COMPARATOR
Intervention: Age of patient
Number of subjects: 300
Study: 8056226

Group type: EXPERIMENTAL
Intervention: Video plus discussion
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Video alone
Number of subjects: 201

Group type: COMPARATOR
Intervention: Discussion alone
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Video plus discussion and Video alone
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Anxiety levels
Number of subjects: 201
Study: 2543656

Group type: EXPERIMENTAL
Intervention: Combined progestin and estrogen (medroxyprogesterone acetate, 20 mg tid, and Premarin, 1.25 mg bid)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 9
Study: 30342058

Group type: EXPERIMENTAL
Intervention: Dual stress challenges (DSC) during exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: Exercise alone (EA)
Number of subjects: 14
Study: 28754155

Group type: EXPERIMENTAL
Intervention: Adenosine stress CMR followed by coronary angiography if myocardial ischemia is detected
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diagnostic coronary angiography and subsequent revascularization according to current guidelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adenosine stress CMR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diagnostic coronary angiography
Number of subjects: 0
Study: 26444863

Group type: EXPERIMENTAL
Intervention: Online monthly self-assessments + 12-month access to a 4-week online automated cognitive behaviour therapy program for binge drinking and depression (DEAL)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Online monthly assessment + DEAL + 12-month access to a social networking site (Breathing Space)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Online monthly self-assessments
Number of subjects: 369
Study: 24565090

Group type: EXPERIMENTAL
Intervention: Propovan®
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diprivan®
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 16
Study: 21390576

Group type: EXPERIMENTAL
Intervention: Chinese medicine therapy for activating blood and dredging collaterals (ABDC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Western medical conventional treatment for anti‐inflammation and immunosuppression
Number of subjects: 34
Study: 19718402

Group type: EXPERIMENTAL
Intervention: Intensive oral hygiene care (tooth brushing instruction, oral health education, supra-gingival scaling conducted every month for 6 months)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (tooth brushing instruction, oral health education, supra-gingival scaling conducted twice at baseline and sixth month)
Number of subjects: 75
Study: 17230495

Group type: EXPERIMENTAL
Intervention: Psychotherapy and relaxation in addition to standardized glucocorticoid therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standardized glucocorticoid therapy (Control)
Number of subjects: 69
Study: 15791376

Group type: EXPERIMENTAL
Intervention: Complete VATS (C-VATS, n = 20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Assisted VATS (A-VATS, n = 19)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Complete VATS (C-VATS)
Number of subjects: 39
Study: 11333065

Group type: EXPERIMENTAL
Intervention: Lithium 20 mg/kg/day
Number of subjects: 15
Study: 9071482

Group type: EXPERIMENTAL
Intervention: Unilateral proximal femur BMD measurement at a cutoff T score of -1
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Unilateral proximal femur BMD measurement
Number of subjects: 266
Study: 8376915

Group type: EXPERIMENTAL
Intervention: S 5682
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 3946364

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg/6 h intravenously to a maximum of 400 mg/4 h
Number of subjects: 44

Group type: COMPARATOR
Intervention: Mylanta II 30 ml/h through a nasogastric tube to a maximum of 90 ml/h
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Mylanta II
Number of subjects: 44
Study: 31979283

Group type: EXPERIMENTAL
Intervention: Combined treatment of Eleutherococcus senticosus (ES) and Drynaria fortunei (DR) extracts for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment of ES and DR extracts
Number of subjects: 0
Study: 29365351

Group type: EXPERIMENTAL
Intervention: icosapent ethyl 4 g/d
Number of subjects: 80
Study: 27343782

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine with 1mL sufentanil (5μg) in group 4
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal bupivacaine with 1mL saline (placebo) in group 3
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal bupivacaine with 1mL saline (placebo) in group 1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine with 1mL sufentanil (5μg) in group 2
Number of subjects: 60
Study: 24824018

Group type: EXPERIMENTAL
Intervention: Sterofundin plus 1% glucose
Number of subjects: 240

Group type: COMPARATOR
Intervention: Normal saline plus 1% glucose
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both groups (Sterofundin and Normal saline)
Number of subjects: 240
Study: 22209106

Group type: EXPERIMENTAL
Intervention: superiorly based vermillion‐mucosal flap and orbicularis oris reconstruction with linear closure
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: superiorly based vermillion‐mucosal flap and orbicularis oris reconstruction with Z‐plasty (both superiorly rotated and inferiorly rotated)
Number of subjects: 31
Study: 20618679

Group type: EXPERIMENTAL
Intervention: Incandescent with dimmer switch slowly increasing the level of light (ISL)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fluorescent with on/off switch rapidly increasing the level of light (FRL)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Incandescent with on/off switch rapidly increasing the level of light (IRL)
Number of subjects: 8
Study: 18399021

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 33

Group type: COMPARATOR
Intervention: Health visitor-delivered non-directive counselling
Number of subjects: 33
Study: 16096450

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia of 33 degrees C
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normothermia (core temperature kept below 38 degrees C with antipyretics and physical means)
Number of subjects: 60
Study: 12418740

Group type: EXPERIMENTAL
Intervention: Chronic dual chamber pacing (DDD)
Number of subjects: 21
Study: 10323386

Group type: EXPERIMENTAL
Intervention: Normocortisolism with hydrocortisone (0.4 mg/kg over 19.5 h)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hypocortisolism (24 h withdrawal of hydrocortisone, followed by 19.5 h saline infusion)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Normocortisolism with naloxone (25 microg/kg x h during last 6.5 h)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hypocortisolism with naloxone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hypocortisolism
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Normocortisolism with naloxone
Number of subjects: 7
Study: 8532302

Group type: EXPERIMENTAL
Intervention: Non-patterned flash visual evoked potentials (VEP's) at several different temporal frequency rates
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Discriminant analysis (DA)
Number of subjects: 33
Study: 1458666

Group type: EXPERIMENTAL
Intervention: 0.125% amorolfine cream
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: 0.25% amorolfine cream
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: 0.5% amorolfine cream
Number of subjects: 725
Study: 6735830

Group type: EXPERIMENTAL
Intervention: Prophylactic ticarcillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31112677

Group type: EXPERIMENTAL
Intervention: IV ibuprofen 60 minutes before surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: IV placebo (100 mL of saline) before surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: IV placebo (100 mL of saline) before and after surgery
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: IV ibuprofen 60 minutes after surgery
Number of subjects: 75
Study: 30407151

Group type: EXPERIMENTAL
Intervention: Oral steroids (20 mg for ages 2-5 years, 30 mg for ages 6-8 years)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Oral steroids
Number of subjects: 389
Study: 26751016

Group type: EXPERIMENTAL
Intervention: AGS‐004
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 25222041

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 10 mg/kg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Vitamin E 10 IU/kg/day
Number of subjects: 75

Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 75
Study: 21593802

Group type: EXPERIMENTAL
Intervention: Social Contingency (SC) intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard Behavioral Weight Loss (SBWL)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Social Contingency (SC) intervention (participants who did not meet weight goals)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard Behavioral Weight Loss (SBWL) (participants who did not meet weight goals)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Successful Social Contingency (SC) participants
Number of subjects: 62

Group type: COMPARATOR
Intervention: Successful Standard Behavioral Weight Loss (SBWL) participants
Number of subjects: 62
Study: 20374988

Group type: EXPERIMENTAL
Intervention: Transitional Work Experience (TWE) services
Number of subjects: 89

Group type: COMPARATOR
Intervention: Job Placement (JP) services
Number of subjects: 89
Study: 18940369

Group type: EXPERIMENTAL
Intervention: Flower essences presented as a spiritual therapy
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Flower essences presented as an affirmation (nonspiritual therapy)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Both groups (spiritual and nonspiritual)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Nonenhanced ritual group
Number of subjects: 251
Study: 16183125

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 0.5% ophthalmic solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gatifloxacin 0.3% ophthalmic solution
Number of subjects: 50
Study: 12577188

Group type: EXPERIMENTAL
Intervention: hPTH (1‐34) for 1 year and HRT
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group treated with only HRT
Number of subjects: 51
Study: 10376113

Group type: EXPERIMENTAL
Intervention: 90 mg dehydroepiandrosterone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 450 mg dehydroepiandrosterone
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 8888928

Group type: EXPERIMENTAL
Intervention: Fortified breast milk (FM-85, Nestle)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Unfortified breast milk
Number of subjects: 11
Study: 2064115

Group type: EXPERIMENTAL
Intervention: 20 mg prednisone daily (n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo daily (n = 8)
Number of subjects: 16
Study: 6862345

Group type: EXPERIMENTAL
Intervention: Heparin-Dihydergot (2 X 5000 IU sodium heparin with 0.5 mg dihydroergotamine)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Calcium heparin (2 X 5000 IU calcium heparin)
Number of subjects: 532

Group type: COMPARATOR
Intervention: Acenocoumarol (Sintrom)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Heparin alone or in combination with dihydroergotamine
Number of subjects: 532
Study: 30414840

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (BoNTA) 250 units
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (BoNTA)
Number of subjects: 130
Study: 27924618

Group type: EXPERIMENTAL
Intervention: Low physical activity levels
Number of subjects: 513

Group type: COMPARATOR
Intervention: Any tobacco use
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Overall CVD-related outcomes
Number of subjects: 513
Study: 25706340

Group type: EXPERIMENTAL
Intervention: Collaborative centralized (CC) reminder/recall notifications
Number of subjects: 18235

Group type: EXPERIMENTAL
Intervention: Collaborative centralized (CC) reminder/recall notifications endorsed by primary care practices
Number of subjects: 18235

Group type: COMPARATOR
Intervention: Practice-based (PB) reminder/recall notifications
Number of subjects: 18235

Group type: EXPERIMENTAL
Intervention: Cost of CC reminder/recall notifications
Number of subjects: 18235

Group type: COMPARATOR
Intervention: Cost of PB reminder/recall notifications
Number of subjects: 18235

Group type: EXPERIMENTAL
Intervention: Adjusted odds ratio for any new immunization in CC vs PB counties
Number of subjects: 18235
Study: 25306143

Group type: EXPERIMENTAL
Intervention: Rapid palatal expander (RPE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: McNamara expander
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 30
Study: 21928901

Group type: EXPERIMENTAL
Intervention: Leisure-only walking
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Utilitarian-only walking
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Freely chosen mixture of leisure and utilitarian walking
Number of subjects: 16
Study: 19947568

Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol (25 mg, tid) + terazosin (2 mg, qn)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Indometacin (25 mg, tid) + terazosin (2 mg, qn)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Terazosin (2 mg, qn)
Number of subjects: 115
Study: 17878213

Group type: EXPERIMENTAL
Intervention: Alcohol (0.6 g/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 15246900

Group type: EXPERIMENTAL
Intervention: Nonpolymeric paclitaxel-coated stents
Number of subjects: 0
Study: 11981385

Group type: EXPERIMENTAL
Intervention: Prednisone (80 mg/d for 4 d, then tapered over 8 d) with valacyclovir (1 g, 3 times a day for 10 days)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Prednisone (80 mg/d for 4 d, then tapered over 8 d) with placebo
Number of subjects: 105
Study: 9468240

Group type: EXPERIMENTAL
Intervention: 6 million units (MU) of human lymphoblastoid interferon daily for 4 weeks, followed by 6 MU three times weekly for an additional 22 weeks (total dose, 564 MU)
Number of subjects: 62

Group type: COMPARATOR
Intervention: 6 MU of interferon three times weekly for an additional 22 weeks (total dose, 564 MU)
Number of subjects: 62

Group type: COMPARATOR
Intervention: 6 MU of interferon daily for 4 weeks followed by 6 MU three times weekly for 18 weeks (total dose, 660 MU)
Number of subjects: 62
Study: 7623388

Group type: EXPERIMENTAL
Intervention: Buprenorphine 2 mg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Methadone 35 mg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Buprenorphine 6 mg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Methadone 65 mg
Number of subjects: 125